01
Cash & equivalents increased 37.2%
Cash & equivalents changed +37.2% from the comparable as-filed period.
$112.8M→$154.7MComparable → current
· Pharmaceutical Preparations
RESEARCH SNAPSHOTArriVent BioPharma, Inc.'s latest supported as-filed period reports net income of -$49.9M, 58.9% below the comparable as-filed period. Every value below links to its SEC accession and metric lineage.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
Cash & equivalents changed +37.2% from the comparable as-filed period.
Net income changed -58.9% from the comparable as-filed period.
Operating income changed -56.7% from the comparable as-filed period.
Research & development changed +52.7% from the comparable as-filed period.
Each point keeps the date investors could first observe it and its accession.
AVBP · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0001104659-26-094902SEC ↗8-KAug 12, 2026Period Aug 11, 20260001104659-26-094869SEC ↗4Jun 22, 2026Period Jun 18, 20260001104659-26-076570SEC ↗4Jun 22, 2026Period Jun 18, 20260001104659-26-076569SEC ↗4Jun 22, 2026Period Jun 18, 20260001104659-26-076567SEC ↗4Jun 22, 2026Period Jun 18, 20260001104659-26-076566SEC ↗8-KJun 22, 2026Period Jun 18, 20260001104659-26-076352SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
| Filed / transacted | Reporting owner | Semantics | Shares | Price | Notional | Source |
|---|---|---|---|---|---|---|
| Jun 18, 2026Filed Jun 22, 2026 | Parsey MerdadDirector | Grant Or AwardDirect | 13,562 | $0 | $0 | Form 4 ↗ |
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Stock-based compensation changed +101.3% from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001104659-26-058706